(1)
Shambhavi, S.; Singh, H.; Ramaprasad, G.; Khikmatov, M.; Vankeshwaram, V.; Ashish, K.; Valladares, C.; Bhatt, T.; Cohen, S. D. Efficacy of Infliximab Versus Vedolizumab in the Management of Immune Checkpoint Inhibitor-Induced Colitis: A Systematic Review and Meta-Analysis. World J Oncol 2025, 16 (4), 331-341. https://doi.org/10.14740/wjon2613.